Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Distribution	1.96B	2.21B	2.30B	2.28B	1.88B
Pharmaceutical Distribution Growth	-11.47%	-3.79%	1.11%	21.05%	7.82%
Pharmaceutical Retail	2.94B	2.69B	1.51B	993.40M	691.07M
Pharmaceutical Retail Growth	9.27%	78.83%	51.53%	43.75%	17.80%
Hospital income	10.66M	14.41M	12.77M	9.45M	14.77M
Hospital income Growth	-26.03%	12.84%	35.12%	-36.01%	259.30%
Drug production revenue	215.15M	299.84M	75.85M	-	-
Drug production revenue Growth	-28.24%	295.32%	-	-	-
Other Income	16.86M	13.33M	8.43M	-	-
Other Income Growth	26.48%	58.04%	-	-	-
Unallocated Other Income	-	-	-	13.50M	6.12M
Unallocated Other Income Growth	-	-	-	120.53%	18.96%
Total	5.14B	5.23B	3.90B	3.29B	2.59B
Total Growth	-1.70%	34.07%	18.56%	27.01%	10.79%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	5.14B	5.23B	3.90B	3.29B	2.59B
China Growth	-1.70%	34.07%	18.56%	27.01%	10.79%
Total	5.14B	5.23B	3.90B	3.29B	2.59B
Total Growth	-1.70%	34.07%	18.56%	27.01%	10.79%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 10, 2026

Data Sources Report a data error